Transcode Therapeutics, Inc. (RNAZ) research

Transcode Therapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$1.57
As of

Transcode Therapeutics, Inc. (RNAZ): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-01.

As of . Source: SEC EDGAR filings for RNAZ. Method and limitations.

SHARE THIS CARD

Share the RNAZ intelligence card

A branded snapshot of RNAZ: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion RNAZ intelligence card preview
Post to X
COMPANY DOSSIER

See the full RNAZ dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for RNAZ on one page. Preview it with sample data, then open it live with a free account.

Preview the RNAZ dossier

Active signals for RNAZ

FREE, NO ACCOUNT

Every signal on RNAZ, as it fires

New filings, 13F moves and cross asset signals on RNAZ land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, RNAZ

RNAZ mentioned in Kresmion daily briefs

RNAZ against its peers

RNAZ's return on equity of -335.4% ranks in the 19th percentile of 12 Biotechnology sub-industry peers, fiscal periods ending between 2025-09-30 and 2025-12-31.

MetricRNAZPeer medianPercentilen
Revenue FYn/a649295n/a10
Operating marginn/a-1575.3%n/a9
Net marginn/a-1106.7%n/a9
Return on equity-335.4%-80.3%1912

Peers (16): ATYR, CNTX, QNCX, CVM, ABVC, KYNB, BRNS, SGMO, LONA, PSTV, HOTH, GNTA, GRDX, ALGS, PVCT, MCRB. Left out: EVAX (no annual filing), IGC (no annual filing), CLCS (period gap), MDNAF (no annual filing), TTIPF (no annual filing), QNTM (no annual filing), VICP (period gap), PLRZ (no annual filing), SEOVF (no annual filing). Fiscal periods ending between 2025-09-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (RNAZ: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more RNAZ signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to RNAZand get the insider, 13F, options, and confluence read in one view.

Preview the RNAZ dossier